Fosteabine
Fosteabine is an oral and proagent analogue of cytarabine which is resistant to deoxycytidine deaminase.
Product Specifications
CAS Number
73532-83-9
Product Name Alternative
Cytarabine ocfosfate; YNK 01
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Fosteabine.html
Solubility
10 mM in DMSO
Smiles
O[C@@H]1[C@H](N2C(N=C(N)C=C2)=O)O[C@H](COP(OCCCCCCCCCCCCCCCCCC)(O)=O)[C@H]1O
Molecular Formula
C27H50N3O8P
Molecular Weight
575.67
References & Citations
[1]Maloisel F, et al. Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase. Leukemia. 2002 Apr;16 (4) :573-80.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881930-100 1x 100 µL
PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042906-100 1x 100 µL
CD72 (B Cell Marker) (BU40), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741944-100 1x 100 µL
TIMP1 (Colorectal and Lymph Node Metastasis Marker) (TIMP1/1944R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472633-100 1x 100 µL
Gastrin (GAST/2633), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
